Teva Of Israel, Other Generics Win U.S. High Court Review Of Labels
This article was originally published in PharmAsia News
Executive Summary
Israel's Teva Pharmaceutical Industries won an initial U.S. victory for generics makers when the U.S. Supreme Court agreed to hear a case concerning labeling